CTLA4 was uniquely identified with a higher degree in the HCC interaction network (Figure 5), while in HCC, CTLA4 interacted with CD86, which may participate negatively in the regulation of T cell activation and diminishment of immune response [29]. This evidence concerns the gene CD86 and hepatocellular carcinoma.